Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
1.615
-0.155 (-8.76%)
At close: Oct 14, 2026, 4:00 PM EDT
1.580
-0.035 (-2.17%)
After-hours: Oct 14, 2026, 7:30 PM EDT
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $5.41 million as of October 14, 2026. It is the 44,627th most valuable company in the world and the 5,976th biggest in the United States. Its market cap has decreased by 71.66% in one year.
Market Cap
5.41M
Enterprise Value
5.22M
1-Year Change
-71.66%
Global Rank
Country Rank
#5,976 United States
Category
ChartMarket Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $5.41M, a decrease of -84.26%. That is a compound annual growth rate of -26.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 4.90M | -24.62% |
| Dec 31, 2025 | 6.50M | 124.14% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
| Oct 2, 2020 | 34.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 5.58M |
| Cardio Diagnostics Holdings | 5.53M |
| Creative Medical Technology Holdings | 5.53M |
| Lexaria Bioscience | 5.49M |
| AIM ImmunoTech | 5.48M |
| Pulmatrix | 5.33M |
| Enlivex | 5.06M |
| Liminatus Pharma | 5.05M |